Navigation Links
Mayo researchers: Dramatic outcomes in prostate cancer study
Date:6/19/2009

ROCHESTER, Minn. -- Two Mayo Clinic patients whose prostate cancer had been considered inoperable are now cancer free thanks in part to an experimental drug therapy that was used in combination with standardized hormone treatment and radiation therapy. The men were participating in a clinical trial of an immunotherapeutic agent called MDX-010 or ipilimumab. In these two cases, physicians say the approach initiated the death of a majority of cancer cells and caused the tumors to shrink dramatically, allowing surgery. In both cases, the aggressive tumors had grown well beyond the prostate into the abdominal areas.

"The goal of the study was to see if we could modestly improve upon current treatments for advanced prostate cancer," says Eugene Kwon, M.D., Mayo Clinic urologist and leader of the clinical trial. "The candidates for this study were people who didn't have a lot of other options. However, we were startled to see responses that far exceeded any of our expectations."

The patients first received a type of hormone therapy called androgen ablation, which removes testosterone and usually causes some initial reduction in tumor size. Researchers then introduced a single dose of ipilimumab, an antibody, which builds on the anti-tumor action of the hormone and causes a much larger immune response, resulting in massive death of the tumor cells. Both men experienced consistent drops in their prostate specific antigen (PSA) counts over the following weeks until both were deemed eligible for surgery. Then, during surgery, came a greater surprise.

"The tumors had shrunk dramatically," says Michael Blute, M.D., Mayo urologist, co-investigator and surgeon, who operated on both men. "I had never seen anything like this before. I had a hard time finding the cancer. At one point the pathologist (who was working during surgery) asked if we were sending him samples from the same patient."

One patient underwent radiation therapy after surgery; both have resumed their regular lives. Further research is being planned to understand more about the mechanisms of the antibody and how best to use the approach in practice. The researchers, however, note the significance of their findings.

"This is one of the holy grails of prostate cancer research," says Dr. Kwon. "We've been looking for this for years."


'/>"/>

Contact: Robert Nellis
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Source:Eurekalert

Related medicine news :

1. HALT-C researchers: Interferon as long-term treatment for hepatitis C not effective
2. Children Tell Researchers: Well Get Fit if Its Fun
3. Researchers: Ban on fast food TV advertising would reverse childhood obesity trends
4. Researchers: Program discourages HIV transmission in Russia
5. Attacks against medical researchers: Time to take a stand
6. Mayo Clinic researchers: Insulin-boosting medication does not impair ability to survive heart attack
7. Mayo researchers: complementary therapies help patients recover after heart surgery
8. OHSU researchers: Surgery, radiation gives early survival advantage in bile duct cancer
9. Mercury in Mackenzie River delta dramatically higher than previously believed
10. Cinergy Health Expands Staff in Face of Dramatic Growth
11. Study Results Show CAQH CORE Certification Dramatically Cuts Administrative Costs, Accelerates I.T. Adoption by Providers and Health Plans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... ... August 16, 2017 , ... ... eBook, 9781498499620    ) shares that during the time of a cancer diagnosis, surgery and ... God's love, and all the many ways God shows love to those who ...
(Date:8/16/2017)... Lake Orion, Rochester, Michigan (PRWEB) , ... August ... ... now offer treatment options to patients suffering from chronic pelvic pain. In ... treatment of various pelvic pain disorders including endometriosis, menorrhagia (abnormal heavy bleeding during ...
(Date:8/16/2017)... ... 16, 2017 , ... With low back pain afflicting 8 of 10 Americans at some point ... – upper back pain. But this equally vexing condition stems from a variety of causes ... Liu, MD, PhD , founder and president of Atlantic Spine Center. , Nestled between ...
(Date:8/15/2017)... ... 15, 2017 , ... Western University of Health Sciences President ... forward in bold new directions while using its foundational values of humanism and ... the traditional opening of the academic year, on August 12, 2017 at Fairplex ...
(Date:8/15/2017)... ... August 15, 2017 , ... An ... who fell into a coma and died after receiving silicone injections for buttock ... performed in the alleged perpetrator’s apartment after the victim was fetched from a ...
Breaking Medicine News(10 mins):
(Date:8/3/2017)... SAN DIEGO , Aug. 3, 2017  Opioid ... crippling diseases driving up healthcare costs and threatening outcomes, ... the lab supply and IVD industry that support them, ... health care market researcher said that drugs of abuse, ... vendors and sessions at the organization,s 69th meeting in ...
(Date:8/2/2017)... Aug. 2, 2017 CaryRx, a next-generation full-service pharmacy, ... service for patients in the Washington D.C. ... pharmacy by providing delivery of medications through the convenience of ... delivery or delivered within one hour to any location in ... to bring this invaluable service to Washington D.C. ...
(Date:7/31/2017)... 31, 2017 7D Surgical, developer of ground breaking ... the 7D Surgical System to support its strategic sales plan ... and Virginia.  7D Surgical has entered into an ... the premier medical facilities within those markets. ... Spartan ...
Breaking Medicine Technology: